A CHEMICAL APPROACH TO ELUCIDATE THE MECHANISM OF TRANSTHYRETIN AND BETA-PROTEIN AMYLOID FIBRIL FORMATION

被引:137
|
作者
KELLY, JW [1 ]
LANSBURY, PT [1 ]
机构
[1] MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA
来源
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 1994年 / 1卷 / 03期
关键词
AMYLOID; TRANSTHYRETIN; AMYLOID BETA PROTEIN; ALZHEIMERS DISEASE; STRUCTURE; MECHANISM;
D O I
10.3109/13506129409148451
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid deposits are associated with a variety of amyloid diseases, although their role in the pathogenesis remains unclear. Detection of amyloid fibrils and/or prevention of their formation appears to be important in the diagnosis and treatment of amyloid diseases such as Alzheimer's disease. The design of therapeutic molecules with this activity requires a detailed understanding of the structure of the amyloid fibril and the mechanism of fibril formation. This review is focused on studies carried out in the laboratories of the authors, who were trained as organic chemists and bring that perspective to their work. The ongoing studies described within have as their ultimate goal the complete description of the molecular mechanism of amyloid formation by two proteins; transthyretin and the amyloid beta protein. The purpose of this review is to outline chemical approaches and methodology which prove to be useful for understanding amyloid fibril formation.
引用
收藏
页码:186 / 205
页数:20
相关论文
共 50 条
  • [1] Interaction of transthyretin with amyloid beta-protein: Binding and inhibition of amyloid formation
    Schwarzman, AL
    Goldgaber, D
    Palha
    Buxbaum, JD
    Saraiva
    Frangione
    Kelly
    Blake
    Kirschner
    Arvinte
    NATURE AND ORIGIN OF AMYLOID FIBRILS, 1996, 199 : 146 - 164
  • [2] Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro
    Tang, MK
    Zhang, JT
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (04): : 380 - 384
  • [3] Effects of beta-protein mutations on amyloid fibril nucleation and elongation
    Teplow, DB
    Lomakin, A
    Benedek, GB
    Kirschner, DA
    Walsh, DM
    ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, 1997, : 311 - 319
  • [4] Inhibition of amyloid beta fibril formation by monomeric human transthyretin
    Garai, Kanchan
    Posey, Ammon E.
    Li, Xinyi
    Buxbaum, Joel N.
    Pappu, Rohit V.
    PROTEIN SCIENCE, 2018, 27 (07) : 1252 - 1261
  • [5] FIBRIL FORMATION BY PRIMATE, RODENT, AND DUTCH-HEMORRHAGIC ANALOGS OF ALZHEIMER AMYLOID BETA-PROTEIN
    FRASER, PE
    NGUYEN, JT
    INOUYE, H
    SUREWICZ, WK
    SELKOE, DJ
    PODLISNY, MB
    KIRSCHNER, DA
    BIOCHEMISTRY, 1992, 31 (44) : 10716 - 10723
  • [6] Inhibiting transthyretin amyloid fibril formation via protein stabilization
    Miroy, GJ
    Lai, ZH
    Lashuel, HA
    Peterson, SA
    Strang, C
    Kelly, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) : 15051 - 15056
  • [7] ALZHEIMERS-DISEASE AND DOWNS-SYNDROME BETA-PROTEIN - A MODEL SYSTEM FOR AMYLOID FIBRIL FORMATION
    CASTANO, EM
    GOREVIC, PD
    SHARMA, R
    FRANGIONE, B
    CLINICAL RESEARCH, 1987, 35 (03): : A417 - A417
  • [8] RELEASE OF EXCESS AMYLOID BETA-PROTEIN FROM A MUTANT AMYLOID BETA-PROTEIN PRECURSOR
    CAI, XD
    GOLDE, TE
    YOUNKIN, SG
    SCIENCE, 1993, 259 (5094) : 514 - 516
  • [9] Oxidation inhibits amyloid fibril formation of transthyretin
    Maleknia, Simin D.
    Reixach, Natalia
    Buxbaum, Joel N.
    FEBS JOURNAL, 2006, 273 (23) : 5400 - 5406
  • [10] TRANSTHYRETIN SEQUESTERS AMYLOID-BETA PROTEIN AND PREVENTS AMYLOID FORMATION
    SCHWARZMAN, AL
    GREGORI, L
    VITEK, MP
    LYUBSKI, S
    STRITTMATTER, WJ
    ENGLHILD, JJ
    BHASIN, R
    SILVERMAN, J
    WEISGRABER, KH
    COYLE, PK
    ZAGORSKI, MG
    TALAFOUS, J
    EISENBERG, M
    SAUNDERS, AM
    ROSES, AD
    GOLDGABER, D
    NEUROBIOLOGY OF AGING, 1994, 15 : S53 - S54